1683 – MRI of the liver, for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques

Page last updated: 03 September 2021

Application Detail

Description of Medical Service

Magnetic Resonance Imaging (MRI) to image the liver. MRI utilises strong, uniform magnetic fields to investigate the anatomy, perfusion, tissue characterisation and function of different organs and systems within the human body.

Description of Medical Condition

MRI of the liver for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques.

Reason for Application

The Diagnostic Imaging Clinical Committee of the MBS Review Taskforce recommended a new MBS item for MRI of the liver for the evaluation of hepatic metastases for initial staging or restaging prior to treatment using interventional techniques. MSAC application 1372.1 was for MRI of the liver for patients with known (CRC) with suspected or proven liver metastases and patients with known or suspected hepatocellular carcinoma (HCC) for the purposes of cancer staging. However, this service is limited to patients with known CRC with suspected or proven liver metastases and patients with known or suspected HCC. A service is required for MRI of the liver for additional oncologic indications.

Medical Service Type

Investigative technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Form

-

Consultation Survey

-
Please provide any comments to commentsMSAC@health.gov.au.

PASC Consultation
Not applicable

MSAC Consultation
MSAC Consultation closes 8 October 2021

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation proves please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

Bypassing PASC

ESC

Bypassing ESC

MSAC

25-26 November 2021